Handelsbanken Fonder Ab Sorrento Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

  • $25.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$0.74 - $1.83 $7,474 - $18,483
10,100 Added 14.62%
79,200 $70,000
Q4 2021

Feb 08, 2022
BUY
$4.65 - $7.23 $36,270 - $56,394
7,800 Added 12.72%
69,100 $321,000
Q2 2021

Aug 03, 2021
BUY
$6.35 - $10.0 $106,680 - $168,000
16,800 Added 37.75%
61,300 $594,000
Q4 2020

Feb 11, 2021
BUY
$5.76 - $11.95 $256,320 - $531,775
44,500 New
44,500 $304,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email